EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Long‐Term Impact of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Implantation

Juri Iwata iD, Kentaro Hayashida iD, Ryo Arita, Tomonari Moriizumi, Akiyoshi Kajino, Shingo Sakata, Toshinobu Ryuzaki, Keitaro Shinada, Hikaru Tsuruta, Yoshitake Yamada, Jungo Kato, Tatsuo Takahashi und 4 weitere

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Juri Iwata und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Thrombosis, Multidetector Computed Tomography, Aortic Valve. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypoattenuated leaflet thickening (HALT) after transcatheter aortic valve implantation (TAVI) detected on multidetector computed tomography (MDCT) is considered leaflet thrombosis. However, its impact on long‐term clinical outcomes remains unclear. This study aimed to investigate the impact of early HALT detection after TAVI on long‐term clinical outcomes and structural valve deterioration beyond 6 years.

Methods

Of the 672 consecutive patients who underwent TAVI between 2013 and 2018, 448 were treated with either SAPIEN XT or SAPIEN 3 and underwent MDCT analysis within 30 days after TAVI. MDCT results and echocardiographic data were analyzed annually.

Results

HALT was detected in 68 (15.2%) of 448 eligible patients within 30 days after TAVI. No significant difference in effective orifice area was observed by echocardiography within 30 days after TAVI between the HALT and the non‐HALT groups in SAPIEN XT (HALT vs. non‐HALT: 1.62 ± 0.66 cm 2 vs. 1.72 ± 0.43 cm 2 ; p = 0.26) and in SAPIEN 3 (1.42 ± 0.35 cm 2 vs. 1.45 ± 0.34 cm 2 ; p = 0.63). No significant differences in all‐cause mortality (52.9% vs. 60.0%; hazard ratio (HR): 1.19; 95% confidence interval (CI): 0.83−1.70; p = 0.3), stroke incidence (5.9% vs. 7.1%; HR: 1.06; 95% CI: 0.08−13.7; p = 0.97), heart failure rehospitalization (10.3% vs. 15.0%; HR: 2.3; 95% CI: 0.89−5.99; p = 0.09), and structural valve deterioration (14.7% vs. 17.9%; HR: 0.89; 95% CI: 0.45−1.73; p = 0.73) were observed between the HALT and the non‐HALT groups during the median follow‐up of 1872 (interquartile range; 1203−2468) days.

Conclusions

HALT within 30 days was not associated with clinical outcomes or hemodynamic performance during long‐term follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementThrombosisMultidetector Computed TomographyAortic ValveAortic Valve StenosisHumansMaleFemaleTime FactorsHeart Valve ProsthesisAged, 80 and overTreatment OutcomeRisk FactorsAgedRetrospective StudiesRisk AssessmentPredictive Value of TestsProsthesis DesignAsymptomatic DiseasesProsthesis Failure

Stichwörter der Autor:innen

balloon‐expandable valvehypoattenuated leaflet thickeninglong‐termstructural valve deteriorationtranscatheter aortic valve implantation

Autor:innen und Institutionen

  • Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Department of Radiology, Keio University School of Medicine, Tokyo, Japan.
  • Department of Anesthesiology, Keio University School of Medicine, Tokyo, Japan.
  • Department of Cardiovascular Surgery, Keio University School of Medicine, Tokyo, Japan.

ORCID-Profile: Juri Iwata, Kentaro Hayashida

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Iwata, J., Hayashida, K., Arita, R., Moriizumi, T., Kajino, A., Sakata, S., Ryuzaki, T., Shinada, K., Tsuruta, H., Yamada, Y., Kato, J., Takahashi, T., Yamazaki, M., Jinzaki, M., Shimizu, H., & Ieda, M. (2025). Long‐Term Impact of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Implantation. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31435

Vancouver

Iwata J, Hayashida K, Arita R, Moriizumi T, Kajino A, Sakata S, et al. Long‐Term Impact of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Implantation. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31435

BibTeX
@article{Iwata2025,
  author = {Iwata, Juri and Hayashida, Kentaro and Arita, Ryo and Moriizumi, Tomonari and Kajino, Akiyoshi and Sakata, Shingo and Ryuzaki, Toshinobu and Shinada, Keitaro and Tsuruta, Hikaru and Yamada, Yoshitake and Kato, Jungo and Takahashi, Tatsuo and Yamazaki, Masataka and Jinzaki, Masahiro and Shimizu, Hideyuki and Ieda, Masaki},
  title = {Long‐Term Impact of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Implantation},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31435}
}
Kostenlos starten →